Toulose, France Clinical Trials

A listing of Toulose, France clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 136 clinical trials
A Study to Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With Spesolimab

This study is open to people with palmoplantar pustulosis who took part in previous clinical studies of a medicine called spesolimab. Participants who benefited from spesolimab treatment in the previous studies can join this study. The purpose of this study is to find out how safe spesolimab is and whether …

palmoplantar pustulosis
HOP l'Archet
 (289.7 away) Contact site
  • 7 views
  • 13 Jun, 2021
  • +66 other locations
A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease

A phase 2 randomized, double blind, placebo controlled study evaluating the efficacy and safety of AL002 in participants with Early Alzheimer's Disease.

amyloidosis
mini-mental state examination
alzheimer's disease
Hospital de La Santa Creu i Sant Pau
 (154.7 away) Contact site
  • 0 views
  • 27 May, 2021
  • +85 other locations
Triple Combination of Pevonedistat and Venetoclax Plus Azacitidine in Adults With Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy

The purpose of this study is to determine whether the combination of pevonedistat + venetoclax + azacitidine improves event-free survival (EFS) compared with venetoclax + azacitidine in patients with newly diagnosed acute myeloid leukemia (AML) who are unfit for intensive chemotherapy.

ejection fraction
hydroxyurea
myelodysplastic syndromes
direct bilirubin
leukapheresis
Centre Hospitalier Universitaire de Clermont ferrand
 (169.8 away) Contact site
  • 2 views
  • 16 May, 2021
  • +58 other locations
A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

The purpose of this study is evaluate the efficacy of teclistamab at the recommended Phase 2 dose (RP2D).

measurable disease
multiple myeloma
P le IUC Oncopole CHU
 (0.5 away) Contact site
  • 0 views
  • 31 May, 2021
  • +69 other locations
Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma

The primary purpose of this study is to evaluate the efficacy of LXH254 combinations in previously treated unresectable or metastatic melanoma

NRAS
targeted therapy
metastatic cutaneous melanoma
metastatic melanoma
combinations
Novartis Investigative Site
 (48.5 away) Contact site
  • 0 views
  • 14 Jun, 2021
  • +31 other locations
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

The purpose of this study is to evaluate the efficacy of talquetamab in participants with relapsed or refractory multiple myeloma at the recommended Phase 2 dose (RP2D) (Part 3).

measurable disease
multiple myeloma
CHU de Montpellier, Hopital Saint-Eloi
 (121.2 away) Contact site
  • 0 views
  • 28 May, 2021
  • +75 other locations
A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease

The primary purpose of this study is to evaluate the effect of JNJ-63733657 versus placebo on cognitive decline using the Alzheimer's Disease Assessment Scale Cognitive subscale 13-item version (ADAS-Cog13).

dementia
alzheimer's disease
cognitive decline
cognitive assessment
H pital Pellegrin CHU Bordeaux
 (131.5 away) Contact site
  • 0 views
  • 03 Jun, 2021
  • +141 other locations
A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors

Researchers are looking for a better way to treat people with solid tumors. Before a treatment can be approved for people to take, researchers do clinical trials to better understand its safety and how it works. In this trial, the researchers want to learn about regorafenib taken together with nivolumab …

Institut Bergoni - Unicancer Nouvelle Aquitaine
 (131.0 away) Contact site
  • 0 views
  • 13 Jun, 2021
  • +42 other locations
Trastuzumab Deruxtecan in Participants With HER2-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)

This study was designed to evaluate the safety and efficacy of trastuzumab deruxtecan in HER2-mutated metastatic non-small cell lung cancer (NSCLC) participants who had disease recurrence or progression during/after at least one regimen of prior anticancer therapy (second line or later) that must have contained a platinum-based chemotherapy drug.

measurable disease
HER2
lung carcinoma
liquid biopsy
erbb2
Hospital Universitario Vall d'Hebron
 (153.9 away) Contact site
  • 0 views
  • 06 Jun, 2021
  • +52 other locations
Low-dose rhIL-2 in Patients With Recently-diagnosed Type 1 Diabetes

Type 1diabetes (T1D) is caused by autoimmune destruction of the pancreatic islet -cells, leading to an absolute deficiency in insulin. In health, regulatory T cells (Tregs) suppress immune responses against normal tissues, and likewise prevent autoimmune diseases. Tregs are insufficient in T1D. The investigators previously showed that administration of low …

heart disease
autoimmune disease
insulin
c-peptide
interleukin-2
Endocrinologie et diab tologie p diatrique, H pital des Enfants - CHU-Bordeaux
 (131.5 away) Contact site
  • 78 views
  • 25 Jan, 2021
  • +43 other locations